The use of anticoagulants is not associated with improved overall survival in patients with pulmonary arterial hypertension, ...
The quest to find an anticoagulant that can prevent strokes, cardiovascular events, and venous thrombosis without significantly increasing risk of bleeding is something of a holy grail in ...
Apixaban (Eliquis) was associated with lower serious bleeding rates than rivaroxaban (Xarelto) or warfarin in patients with cirrhosis and atrial fibrillation (AF, Afib) in a nationwide cohort study.
Credit: Getty Images New research is being conducted on factor XI inhibitor therapy as the patent expiration for factor Xa inhibitors nears. Factor XI inhibitor therapy research is being conducted as ...
New anticoagulant platform, offering hope for advances for heart surgery, dialysis, other procedures
While blood clotting is important to prevent blood loss and for our immunity, coagulation also can cause health issues and even death. Now, a new biomolecular anticoagulant platform holds promise as a ...
New York, April 01, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Anticoagulant Reversal Drug Market - Premium Insight, Competitive News Feed Analysis, Company ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback